| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
| 02/28/2012 | US8124066 Methods of using interleukin-2 mutants with reduced toxicity |
| 02/28/2012 | US8124065 Cytokine Protein Family |
| 02/28/2012 | US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making |
| 02/28/2012 | CA2550296C Methods of use of probiotic bifidobacteria for companion animals |
| 02/28/2012 | CA2514019C Topical pharmaceutical and/or cosmetic dispense systems |
| 02/28/2012 | CA2333951C Method for treating neurodegenerative disorders |
| 02/28/2012 | CA2289652C Methods of enhancing functioning of the upper gastrointestinal tract |
| 02/23/2012 | WO2012023622A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention |
| 02/23/2012 | WO2012023345A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 02/23/2012 | WO2012023285A1 Ehmt2 as a target gene for cancer therapy and diagnosis |
| 02/23/2012 | WO2012022796A2 Novel combinations |
| 02/23/2012 | WO2012022740A1 Combination treatment of multiple sclerosis |
| 02/23/2012 | WO2012022724A1 Combination anti - cancer therapy |
| 02/23/2012 | WO2012022677A2 Novel combination therapy for the treatment of cancer |
| 02/23/2012 | WO2011128407A3 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
| 02/23/2012 | WO2011093819A3 New pharmaceutical combination comprising tiotropium |
| 02/23/2012 | WO2011093818A3 Pharmaceutical compositions comprising salmeterol and fluticasone |
| 02/23/2012 | WO2011093811A3 Pharmaceutical preparations comprising formoterol and fluticasone |
| 02/23/2012 | WO2011093809A3 Dry powder pharmaceutical composition comprising tiotropium and ciclesonide |
| 02/23/2012 | WO2011060290A3 Immediate release tablet formulations |
| 02/23/2012 | US20120046968 Systems and methods for providing a stem cell bank |
| 02/23/2012 | US20120046281 Rifalazil compositions and therapeutic regimens |
| 02/23/2012 | US20120046276 Tuberculosis treatment using pleuromutilin derivatives |
| 02/23/2012 | US20120045487 Multiphasic microfibers for spatially guided cell growth |
| 02/23/2012 | US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor |
| 02/23/2012 | DE102010039631A1 Pharmaceutical composition, useful e.g. for immunomodulatory and/or immunosuppressive therapy of autoimmune diseases, comprises inhibitors of proteasome or immunoproteasome in combination with e.g. calcium channel antagonists |
| 02/23/2012 | CA2807222A1 Combination anti - cancer therapy |
| 02/23/2012 | CA2807218A1 Novel combination therapy for the treatment of cancer |
| 02/22/2012 | EP2420490A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 02/22/2012 | EP2420235A1 Methods and combination therapies for treating alzheimer's disease |
| 02/22/2012 | EP2419176A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus |
| 02/22/2012 | EP2419135A1 Combination therapy using an anti-egfr agent(s) and igf-1r specific inhibitors |
| 02/22/2012 | EP2419115A2 Composition for regulating the metabolism of lipids |
| 02/22/2012 | EP2419104A2 5-ht4 receptor agonist compounds for treatment of cognitive disorders |
| 02/22/2012 | EP2419097A1 Pharmaceutical compositions |
| 02/22/2012 | EP2419095A2 Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses |
| 02/22/2012 | EP2418965A1 Hydroxytyrosol combinations for enhancing mitochondrial function and energy production |
| 02/22/2012 | EP1948237B8 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 02/22/2012 | EP1901776B1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance |
| 02/22/2012 | EP1668013B1 Pyrazolopyrrole derivatives as protein kinase inhibitors |
| 02/22/2012 | EP1590328B1 (2-carboxamido) (3-amino) thiophene compounds |
| 02/22/2012 | EP1575566B1 Multilayer dosage forms containing naproxen and triptans |
| 02/22/2012 | EP1541151B1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | EP1532278B1 Diagnosis of chronic rejection |
| 02/22/2012 | EP1514542B1 Medicinal composition comprising Tacrine or Donepezil for improving brain function. |
| 02/22/2012 | EP1389121B1 Method and compositions for treating mammalian nerve tissue injuries |
| 02/22/2012 | EP1095183B1 Methods for the diagnosis and treatment of lung cancer |
| 02/22/2012 | EP0979080B9 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/22/2012 | CN202146434U 一种降压药组合物 An antihypertensive drug composition |
| 02/22/2012 | CN102361638A Transdermal preparation |
| 02/22/2012 | CN102358746A 表面活性钙磷酸盐 Calcium phosphate surfactants |
| 02/22/2012 | CN102357249A Medicine for inhibiting medicine-resistant tubercle bacillus |
| 02/22/2012 | CN102357248A Sex steroid precursor alone or in combination with a selective estrogen receptor modulator for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
| 02/22/2012 | CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/22/2012 | CN102357226A Application of Chinese herbal medicine turmeric extraction in preparation of slimming and lipid-lowering drug or drug with lipase activity inhibition effect |
| 02/22/2012 | CN102357150A Application of extractive of Chinese herbal medicine medlar to prepare weight-losing lipid-lowering medicines or medicines with effects of inhibiting lipase activity |
| 02/22/2012 | CN102357142A Use of water extract or ethanol extract of Chinese herbal medicine seville orange flower in preparation of drug for losing weight and reducing blood fat or drug for inhibiting lipase activity |
| 02/22/2012 | CN102357141A Application of Chinese herbal medicine bitter orange extract to preparation of medicament for losing weight and reducing fat or medicament with lipase activity inhabiting function |
| 02/22/2012 | CN102357136A Application of Chinese herbal medicine papaya extract to preparation of medicament for losing weight and reducing fat or medicament with lipase activity inhabiting function |
| 02/22/2012 | CN102357128A Application of extractive of Chinese herbal medicine cortex moutan to prepare weight-losing lipid-lowering medicines or medicines with effects of inhibiting lipase activity |
| 02/22/2012 | CN102357126A Application of Chinese herbal medicine caulis polygoni multiflori extract in preparing weight-losing and lipid-lowering medicaments or in preparing medicaments with lipase activity inhibition effect |
| 02/22/2012 | CN102357120A Application of extractive of Chinese herbal medicine scutellaria baicalensis to prepare medicines with effects of inhibiting lipase activity |
| 02/22/2012 | CN102357114A Application of Chinese herbal medicine kudzu root extracts in preparation of weight-losing lipid-lowering medicines or medicines with lipase activity inhibition effect |
| 02/22/2012 | CN102357113A Application of Chinese herbal medicine fiveleaf gynostemma in preparation of weight-reducing lipid-lowering drug or in preparation of drug with lipase activity inhibition effect |
| 02/22/2012 | CN102357109A Use of water extract or ethanol extract of Chinese herbal medicine radix cynanchi atrati in preparation of drug for losing weight and reducing blood fat or drug for inhibiting lipase activity |
| 02/22/2012 | CN102357106A Application of Chinese herbal medicine campsis grandiflora extracts in preparation of weight-losing lipid-lowering medicines or medicines with lipase activity inhibition effect |
| 02/22/2012 | CN102000334B 用于治疗抑郁症的复方制剂 For the treatment of depression compound preparation |
| 02/22/2012 | CN101524353B 口服抗过敏复方药物组合物 Oral anti-allergy compound pharmaceutical composition |
| 02/21/2012 | US8119689 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 02/21/2012 | US8119678 Compounds, compositions and methods |
| 02/21/2012 | US8119649 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 02/21/2012 | US8119619 Pregnane steroids and their use in the treatment of CNS disorders |
| 02/21/2012 | US8119618 Compositions and methods for the treatment of inflammatory diseases |
| 02/21/2012 | US8119609 Apoptosis and increased production of ceramides and DAG are normalized in the presence of antioxidants |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119405 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/21/2012 | US8119397 Therapeutic agents and therapeutic methods for treating injured tissue |
| 02/21/2012 | US8119167 Food supplement composition suitable for promoting iron absorption |
| 02/21/2012 | US8119154 Sustained release intraocular implants and related methods |
| 02/21/2012 | US8119138 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | CA2650399C Gpr119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto |
| 02/21/2012 | CA2512797C Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2487362C Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 02/21/2012 | CA2472399C Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2442204C Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 02/21/2012 | CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/21/2012 | CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/21/2012 | CA2328074C Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 02/21/2012 | CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
| 02/21/2012 | CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 02/16/2012 | WO2012020839A1 Pharmaceutical composition for cancer therapy |
| 02/16/2012 | WO2012020836A1 Therapeutic agent for hepatitis c containing rrm2 antagonist as active ingredient |
| 02/16/2012 | WO2012020370A1 Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses |